Japan - HealthQuill

AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.

AstraZeneca’s drug to treat rare blood vessel disease gets EU nod

AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.

by HealthQuill
October 28, 2024
0 Comments

Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.

Drugs Health Pharma

Astellas Pharma gets US regulator’s nod for its gastric cancer drug

Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.

by HealthQuill
October 21, 2024
0 Comments

Regeneron Pharmaceuticals and Sanofi’s drug, Dupixent, got the US regulator’s approval to treat patients with chronic obstructive pulmonary disease.

Drugs Health Pharma

Regeneron-Sanofi’s drug for lung disease gets US approval

Regeneron Pharmaceuticals and Sanofi’s drug, Dupixent, got the US regulator’s approval to treat patients with chronic obstructive pulmonary disease.

by HealthQuill
September 29, 2024
0 Comments

The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.

Drugs Health Pharma

AstraZeneca’s rare disease drug Fasenra gets US regulator’s nod

The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.

by HealthQuill
September 18, 2024
0 Comments

https://www.merck.com/product/usa/pi_circulars/g/gardasil_9/gardasil_9_ppi.pdf

Drugs Health Pharma

Merck meets main goal during end-stage trial of HPV vaccine in Japan

Merck & Co., announced it has met its primary and secondary goals during the end-stage trials of its human papillomavirus (HPV) vaccine in.

by HealthQuill
September 11, 2024
0 Comments

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

by HealthQuill
August 20, 2024
0 Comments

https://www.merck.com/news/daiichi-sankyo-and-merck-enter-into-global-development-and-commercialization-agreement-for-mk-6070/

Drugs Health Pharma

Daiichi Sankyo to pay Merck $170 million for cancer test drug rights

Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for.

by HealthQuill
August 6, 2024
0 Comments

Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.

Drugs Health Pharma

Urine tests can detect cervical cancer viruses, make screening easy

Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.

by HealthQuill
July 17, 2024
0 Comments

AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival

Drugs Health Pharma

AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival

HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.